Author: Sarfaraz K. Niazi
Edition: 2
Publisher: CRC Press
Binding: Hardcover
ISBN: 1420081268
Handbook of Pharmaceutical Manufacturing Formulations: Semisolid Products
The fourth volume in the series covers the techniques and technologies involved in the preparation of semisolid products such as ointments, creams, gels, suppositories, and special topical dosage forms. Medical books Handbook of Pharmaceutical Manufacturing Formulations. Medical books Handbook of Pharmaceutical Manufacturing Formulations. Crc Press | 2004 | 256 pages | ISBN-13: 9780849317484 | ISBN-10: 0849317487
Download link for Handbook of Pharmaceutical Manufacturing Formulations: Semisolids Products
Crc Press | 2004 | 256 pages | ISBN-13: 9780849317484 | ISBN-10: 0849317487
Handbook of Pharmaceutical Manufacturing Formulations, Second Edition, Volume 6: Sterile Products, ISBN-13: 9781420081305, ISBN-10: 1420081306
Buy Handbook of Pharmaceutical Manufacturing Formulations: Uncompressed Solid Products (Volume 2 of 6) by Niazi, Sarfaraz K. and Read this Book on Kobo's Free Apps. Discover Kobo's Vast Collection of Ebooks Today - Over 3 Million Titles, Including 2 Million Free Ones!
author sarfaraz k niazi format hardback language english publication year 27 04 2004 subject engineering technology subject 2 industrial chemistry manufacturing title handbook of pharmaceutical manufacturing formulations liquid products volume 3 of 6 author niazi sarfaraz k publisher crc pr i llc publication date apr 01 2004 pages 320 binding hardcover edition 1 st dimensions 8 50 wx 11 00 hx 0 75 d isbn 0849317487 subject technology engineering manufacturing description the third volume in th
Medical Book Handbook of Pharmaceutical Manufacturing Formulations
Drug manufacturers need a thorough understanding of the specific requirements that regulatory agencies impose on the formulation and efficacy determination of drugs contained in these formulations.
Highlights from Semisolid Products, Volume Four include:
- coverage of over 350 formulations
- valuable information on the difficult area of compliance
- changes to approved new drug applications and abbreviated new drug applications
- the evolving guidelines of ICH and when to conduct a regulatory review
